It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...
WellSpan is proud to share that Dr. Mitchell Crawford, medical director for addiction services and medical director for the WellSpan Specialized Treatment and Recovery Team (START) Program, was ...
Opioid overdoses kill each day. But it's easier to access fentanyl in Arizona than the medications that can help keep people ...
Vermont Business Magazine A longtime Emergency Department (ED) physician and clinical leader at University of Vermont Health ...
Digital addiction endangers minds and values. Mindful tech use, critical thinking, and balanced screen time can help.
The School of Medicine is a major international centre for teaching and research, and committed to the pursuit of improved human health. We combine progressive healthcare education and patient care ...
In an era where innovation and resilience define the future, a select group of trailblazing individuals is setting the ...
WACO, Texas (KWTX) - A Central Texas mom whose story has inspired many after overcoming abuse and a drug addiction that led to multiple arrests held a successful book launch for her new 21-day ...
Vertex Pharmaceuticals A new painkiller has been approved for the first time in 25 years — and there's no risk of addiction ... million Americans prescribed medicine to treat their acute ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries. It’s the first new pharmaceutical approach to ...
Copyright 2025 The Associated Press. All Rights Reserved. U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and ...
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated ... a pharmacist and pain medicine expert who was not involved in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results